CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 81 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-18 | Gillheeney Gary S. President and CEO | Sale | −86,531 | $5.46 | $472K | 398,242 |
| 2022-05-18 | Gillheeney Gary S. President and CEO | Option exercise · Stock Option (Right to Buy) | −86,531 | 1,251,073 | ||
| 2022-05-17 | Gillheeney Gary S. President and CEO | Option exercise | +98,078 | $0.99 | $97K | 496,320 |
| 2022-05-17 | Gillheeney Gary S. President and CEO | Sale | −98,078 | $5.90 | $579K | 398,242 |
| 2022-05-17 | Gillheeney Gary S. President and CEO | Option exercise · Stock Option (Right to Buy) | −98,078 | 1,337,604 | ||
| 2022-05-16 | KATZ MICHAEL W 10% owner | Purchase | +4,000 | $5.99 | $24K | 64,382 |
| 2022-05-16 | KATZ MICHAEL W 10% owner | Purchase | +3,000 | $6.02 | $18K | 67,382 |
| 2022-05-16 | KATZ MICHAEL W 10% owner | Purchase | +3,000 | $6.10 | $18K | 70,382 |
| 2022-05-16 | Gillheeney Gary S. President and CEO | Option exercise | +80,369 | $0.99 | $80K | 478,611 |
| 2022-05-16 | Gillheeney Gary S. President and CEO | Sale | −80,369 | $5.92 | $476K | 398,242 |
| 2022-05-16 | Gillheeney Gary S. President and CEO | Option exercise · Stock Option (Right to Buy) | −80,369 | 1,435,682 | ||
| 2022-05-13 | Gillheeney Gary S. President and CEO | Option exercise | +14,810 | $0.99 | $15K | 413,052 |
| 2022-05-13 | Gillheeney Gary S. President and CEO | Option exercise | +121,580 | $0.99 | $120K | 534,632 |
| 2022-05-13 | Gillheeney Gary S. President and CEO | Sale | −14,810 | $6.06 | $90K | 519,822 |
| 2022-05-13 | Gillheeney Gary S. President and CEO | Sale | −121,580 | $6.18 | $751K | 398,242 |
| 2022-05-13 | Gillheeney Gary S. President and CEO | Option exercise · Stock Option (Right to Buy) | −14,810 | 505,050 | ||
| 2022-05-13 | Gillheeney Gary S. President and CEO | Option exercise · Stock Option (Right to Buy) | −121,580 | 1,516,051 | ||
| 2022-05-03 | Quintero Gilberto Director | Grant or award | +23,913 | 23,913 | ||
| 2022-05-03 | Korfin Michele Ilene Director | Grant or award | +23,913 | 23,913 | ||
| 2022-04-01 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −1,977 | $7.89 | $16K | 86,939 |
Page 17 of 24 · 473 trades